Policy & Legislation
News on government policy and legislation impacting life science and diagnostics.
Diagnostic Testing, Disease Preparedness Bills Introduced in Congress
The plan is intended to facilitate the innovation and development of diagnostics between the private and public sectors during public health emergencies.
Bills in the House and Senate would establish Part B coverage for pharmacy testing for diseases like COVID-19, flu, respiratory syncytial virus, and strep throat.
BIVDA Report Outlines UK Access Barriers to Genetic, Genomic Diagnostics
Challenges identified in the white paper include a lack of centralized guidance to apply for funding for genomic technologies and a shortage of infrastructure to educate physicians and patients.
UK COVID-19 Test Procurement Process Flawed, BIVDA White Paper Says
A BIVDA official said the report could foster better cooperation between the government and industry moving ahead.
AACC Releases Guidelines on Use of Procalcitonin Tests
Tests for procalcitonin, a marker of infection, have only recently become available in the US, leading to uncertainty about their use, according to the AACC.